niceritrol has been researched along with Arteriosclerosis, Coronary in 1 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murase, T | 1 |
1 review available for niceritrol and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
[High Lp (a) concentrations].
Topics: Arteriosclerosis; Blood Component Removal; Coronary Artery Disease; Humans; Hyperlipoproteinemias; H | 1998 |